Cardiovascular Effects of COVID-19 - What Do We Know and Where Should We Go?

Amongst the many challenges of the global pandemic, understanding the effects of coronavirus disease. 2019 (COVID-19) on the cardiovascular system has emerged as a key priority. Emerging, data indicate possible roles for carthac biomarkers and cardiac imaging in me prognostic assessment of these patients, as well as implications of the vascular endotheiium in the pathogenesis' of the condition. From a therapeutic perspective, early data suggest that the provision of well-established treatments for cardiovascular disease, whether with angiotensin-converting enzyme inhibitors or primary angioplasty, is likely to be beneficial. These early data are of limited quality however, and robust studies are needed to address many of the key remaining questions.